About the Summit
A central goal for this meeting is to establish a working consensus on the definition of “cure” in myeloma with international thought leaders on myeloma. Dedicated sessions will evaluate key parameters including depth and durability of minimal residual disease (MRD) negativity, advanced imaging, mass spectrometry, immune reconstitution, time off therapy, restoration of normal function, and potential reversion to an MGUS-like state. These metrics will be discussed under the guidance of leading investigators and clinicians.

Access to Virtual Platform
Virtual platform: https://virtual.imsevents.org/event/curesummit

To login, simply use the email address you registered with. On your first login, you'll receive a one-time code sent to that same email. Enter the code, and you'll have full access to the virtual meeting platform.